Obesity Medication Use Remains Low Among Children | ADA 2025
Drug Topics
JUNE 25, 2025
of YA with obesity were prescribed OMs—predominantly GLP-1s approved for adults but used off label for younger people. Despite the high prevalence of obesity among children and YA, OM utilization remains low,” wrote authors of the abstract. 1 In the final year of the analysis (2024), just 1.5% of adolescents and 5.7%
Let's personalize your content